Breast Surgery Follow-Up Study with Imaging Technology
This study follows patients who had breast surgery using special imaging tools (MOLLI, SPY-PHI, or SPY AGENT GREEN) to see how well these tools help surgeons and how patients recover. Your information helps doctors understand if these tools work safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were at least 18 years old when you had your breast surgery
- You had breast surgery using one of these imaging tools: MOLLI, SPY-PHI, or SPY AGENT GREEN
- Your surgery was on or after January 2022
- At least 1 month has passed since your surgery
- You were not pregnant or breastfeeding at the time of your surgery
- You are not currently enrolled in another experimental drug or device study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects breast cancer imaging tests to build a teaching library. You can join if you are 18 or older and have had a breast imaging test in the US.
This study looks at a more personalized way to follow up after breast-conserving surgery (lumpectomy). It may use extra imaging scans to detect any return of cancer early, which could help you feel more secure and get treatment sooner if needed.
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
This study uses molecular breast imaging (MBI) to help guide biopsies for women with breast abnormalities. It has two parts: one for women with past MBI findings that turned out to be benign, and another for women who need a biopsy now based on recent imaging.
This trial looks at new tools to detect lymphedema (breast or arm swelling) after breast cancer treatment. If you had breast-conserving surgery, radiation, and have finished active therapy (except certain hormone treatments), researchers want to see if a simple device can spot fluid buildup early.
This trial tests a new imaging technique that uses a special dye and light to help surgeons see exactly where the tumor ends during breast cancer surgery, so they can remove the whole tumor while sparing healthy tissue. It may help reduce the chance of leaving cancer cells behind.
Hear when a new Breast Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.